Efficacy and safety of Cerebrolysin in moderate to moderately severe Alzheimer's disease: results of a randomized, double-blind, controlled trial investigating three dosages of Cerebrolysin

European Journal of Neurology (2011) - Comments
pubmed: 20500802 doi: 10.1111/j.1468-1331.2010.03092.x issn: 1468-1331

X A Alvarez, R Cacabelos, C Sampedro, M Aleixandre, C Linares, E Granizo, E Doppler, H Moessler